Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Green Stream Holdings, Inc. To Engage A Stock Buyback Program
The Company Has No Present Plans For Reverse Split And Restates It Is Addressing Program To Alleviate Dilution Of the Company’s Stock
August 16, 2022 04:00 ET | Source: Green Stream Holdings Inc.
...
NEW YORK, NY, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Green Stream Holdings Inc. (OTC PINK: GSFI) ("the Company") (https://greensolarutility.com), an emerging leader in the solar utility and finance space, in response to shareholder requests for updates, today reiterated that it will use debt to employ a leveraged buyback program, and has, at present, no plans for a reverse stock split.
The stock buyback program will allow the Company to repurchase shares of the Company’s common stock. The frequency and amount of the stock buyback will be determined by U.S. Securities and Exchange Commission (SEC) regulations and revenue.
A stock buyback occurs when a company buys back its shares from the marketplace. The effect of a buyback is to reduce the number of outstanding shares on the market, which increases the ownership stake of the stakeholders. Companies usually buy back shares because it believes the market has discounted its shares too steeply, to invest in itself or to improve its financial ratios.
CEO James DiPrima said: “We have also been significantly reducing Company debts and via our S-1 filing, we will be able to utilize those funds to enter into a buyback program to address the dilution of the Company’s stock. This allows us to not plan to enter into a reverse stock split, at this time.
By taking this path, we can increase shareholder value, while maintaining sufficient cash reserves to fund our business operations. We will buy back as many shares as possible and as fast as we can.”
About Green Stream Finance, Inc.
Green Stream Finance, Inc., a solar utility and finance company with satellite offices in Malibu, CA and New York, NY, is focused on exploiting currently unmet markets in the solar energy space, and is currently licensed in California, Nevada, Arizona, Washington, New York, New Jersey, Massachusetts, New Mexico, Colorado, Hawaii, and Canada. The Company’s next-generation solar greenhouses constructed and managed by Green Rain Solar, LLC, a Nevada-based division, utilize proprietary greenhouse technology and trademarked design developed by world-renowned architect Mr. Antony Morali. The Company is currently targeting high-growth solar market segments for its advanced solar greenhouse and advanced solar battery products. The Company has a growing footprint in the significantly underserved solar market in New York City where it is targeting 50,000 to 100,000 square feet of rooftop space for the installation of its solar panels. Green Stream is looking to forge key partnership with major investment groups, brokers, and private investors in order to capitalize on a variety of unique investment opportunities in the commercial solar energy markets. The Company is dedicated to becoming a major player in this critical space. Through its innovative solar product offerings and industry partnerships, the Company is well-positioned to become a significant player in the solar space.
Forward-Looking Statements:
This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. That includes the possibility that the business outlined in this press release cannot be concluded for some reason. That could be as a result of technical, installation, permitting or other problems that were not anticipated. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Green Stream Finance, Inc. to be materially different from the statements made herein. Except for any obligation under the U.S. federal securities laws, Green Stream Finance, Inc. undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.
For All Inquiries Contact:
president@greenstreamfinance.com
Website: greensolarutility.com
SOURCE: Green Stream Holdings Inc.
$GSFI ready to go supersonic $$$$$
$AVCT ready to roll north $$$$
No doubt, looking good ??
Now you're talking, GSFI ready to breakout.
That about sums it up $GSFI
Ready for action
$AVCT
Make mine a double squeeze.
$COSM
I can see dollar island on the horizon, see you there. $MOHO
Dark pool shorts are in big trouble, next week will be awesome.
CEO owns 12m that leaves a micro float of 13.5m not to mention the float is short plus some. This is a powderkeg..
Awesome C.J. Rodger that, ready to run
I'm in
Smells like rocket fuel
100% correct
Throttle up $$$$
Ready to rock.
I'm in
Let it roll, me too
$$$$$ EMGE $$$$$
Me too
Emergent Health (OTCMKTS: EMGE) Big Week as RM Runner Closes on Acquisitions and Looks to Go Fully Reporting
By
Boe Rimes
July 30, 2022
Emergent Health (OTCMKTS: EMGE) continues to make steady gains up the charts in recent trading running all of last week and closing the week off strong up 25% on Friday on $1 million in dollar volume. The stock is under heavy accumulation and is quickly turning into one of the top most searched for stocks on the OTC. Blessed with a tight share structure EMGE is one reverse merger that has not disappointed so far and has a lot of room to grow. EMGE is now closing on the acquisition of Regen Biowellness, Inc. a distributor of various products in the plant-based and regenerative medical fields and bringing on executive Jim Morrison, the former president of L’Oréal as the new CEO of Emergent upon the acquisition of Evolutionary Biologics, expected to close within the next three weeks. Emergent plans to create a complete human and pet portfolio and become a major participant in the field of OTC human and pet products. Fusion Specialty Pharmacy is a nationally accredited compounding pharmacy licensed in 27 states and located in St. George, Utah dedicated to formulating creative, individualized, and compounded medications. Fusion generated $3,801,497 in 2021 Revenues, an approximate 100% increase from 2020 Revenues of $1,971,599. New CEO Jim Morrison has big plans for Emergent including continued growth through acquisition, becoming fully reporting and uplisting to the big boards.
EMGE is making some big moves reporting last week its pending Acquisition Evolutionary Biologics, Inc., engages By Design Medical, a DBA of Aesthetics By Design to market, sell and distribute Regenerative Medicine Products produced by Evolutionary Biologics. The initial focus shall be Exo Elixir TM, a sub-dermal regenerative serum derived from dermal fibroblast stem cells with a proprietary mixture of growth factors, cytokines, collagen, and soluble matrix proteins ideal for skin cells to regenerate themselves to the Aesthetic Trade. The global biologics market size was valued at US $366.43 billion in 2021 and it is expected to hit over US$ 719.84 billion by 2030 with a noteworthy CAGR of 7.8% from 2022 to 2030. The Company also retained Imagemme, a leading award-winning creative branding and packaging studio to create “The Wholistic Company”, a consolidation of its current and future health, wellness and regenerative products. The intent is to have uniform branding and develop marketing and distribution strategies for multi-channel sales approaches. This new brand will be marketed via on-line direct to consumer sales, traditional retail sales and other forms of sales channels, including TV Shopping and “Contact Purchasing.”
Emergent Health (OTCMKTS: EMGE) Curates Companies and Products, Develops and Sells in the Regenerative Health Space … Its products comprise ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. PharmaZu Corp., its newly acquired subsidiary, is a pure play, e-commerce products and service provider focused on The Pet Community, Pet Pharmacy and Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease.
Jim Morrison, President and CEO of Regen has agreed to join Emergents Board of Directors upon the acquisition of Regen and additionally become the full-time CEO of Emergent upon the acquisition of Evolutionary Biologics. Emergent recently executed a letter of intent to acquire Evolutionary Biologics. The acquisition is expected to close within the next three weeks. Mr. Morrison is a legend in the personal care industry, most notably as President of L’Oréal. While at L’Oréal, Morrison oversaw growth that averaged more than 20% year-over-year. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. He is considered one of the top brand strategists in the personal care space. Morrison has had a long history of working with celebrities in the beauty space. Business Week Magazine previously wrote, “Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry’s history no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the American Beauty Industry is unmatched.”
Regen Biowellness products include:
Product with Issued Patents
Immuniain TM (Immune Booster) – Irreversibly-inactivated pepsinogen fragments for modulating immune function (Immune Booster- FDA Cleared) ImmunaZin contains an FDA approved New Dietary Ingredient (NDI), and the NDI # is 1140 Patent No. US 8,309,072; Patent Issued: November 13, 2012
Pending Patent Applications
Veterinary Cannabinoid and Menthol Compositions and Methods
Application No. 16/419,392; International Application PCT/US2019/048695
Cannabinoid and Menthol Compositions and Methods
US Application No. 16/419,336; International Application PCT/US2019/048691
Thin Film Toothpaste Strip, European Application
Product Name: KidzStrips ®
Thin Film Toothpaste Strip, Eurasian Application
Product Name: KidzStrips ®
Fertilizer
Product Name: HydroSoil ®, Water retaining Hemp enhanced fertilizer, water plant once every two weeks
Other Products
IcyEase
Adhesive Ice Pack for muscle/joint pain to cool surface and address pain.
Patent-pending, FDA pain claim in progress. IcyEase contains menthol, menthol is an approved pain relief ingredient in the FDA’s monograph for topical pain relief
Micro Voltage Trans Derm C
Patent application in progress for pain with unique and superior absorbing features due to wearer’s movement generated Micro Voltage
Silverpro – our only FDA approved medical device for the treatment of pain. Revolutionary technology combining genuine silver yarn with low-static carbon fibers, to create the world’s most advanced-compression pain relief fabric
To Find out the inside Scoop on EMGE Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
EMGE
EMGE reported last week its pending Acquisition Evolutionary Biologics, Inc., (Evolutionary Biologics), a market leading innovator of regenerative biological products using science and technology to build products creating external beauty engages By Design Medical, a DBA of Aesthetics By Design to market, sell and distribute Regenerative Medicine Products produced by Evolutionary Biologics. The initial focus shall be Exo Elixir TM, a sub-dermal regenerative serum derived from dermal fibroblast stem cells (does not contain any live cells) with a proprietary mixture of growth factors, cytokines, collagen, and soluble matrix proteins ideal for skin cells to regenerate themselves to the Aesthetic Trade. The global biologics market size was valued at US $366.43 billion in 2021 and it is expected to hit over US$ 719.84 billion by 2030 with a noteworthy CAGR of 7.8% from 2022 to 2030Tamara Paul, CEO of By Design Medical, a DBA of Aesthetics By Design stated “Aesthetics By Design is pleased to begin the collaboration with Evolutionary Biologics. Together our companies will change the landscape of regenerative medicine and launch revolutionary innovated products into the aesthetics market. The acquisition of Evolutionary Biologics by Emergent Health is expected to close within the next two weeks.
On July 28 EMGE announced it has retained Imagemme, a leading award-winning creative branding and packaging studio to create “The Wholistic Company”, a consolidation of its current and future health, wellness and regenerative products. The intent is to have uniform branding and develop marketing and distribution strategies for multi-channel sales approaches. This new brand will be marketed via on-line direct to consumer sales, traditional retail sales and other forms of sales channels, including TV Shopping and “Contact Purchasing.”
James W. Zimbler, CEO of Emergent stated, “I couldn’t be happier about the anticipated opportunity to combine and brand our current line of quality products with Regen Biowellness and Evolutionary Biologics fantastic respective product lines into one consistent brand. With the addition and expected addition to our management team of Marvin Segel, son of QVC Founder Joseph Segel with over 20 years of direct-to-consumer TV and marketing success and Jim Morrison, a legend in the personal care industry, most notably as President of L’Oréal, we believe Emergent’s newly formed brand “The Wholistic Company”, will become a recognizable household name to consumers.”
Jim Morrison, President/CEO of Evolutionary Biologics, stated, “Imagemme is a cutting-edge branding agency. They have the ability to create a memorable brand for “The Wholistic Company” based upon the extensive portfolio of products that our combined companies will own and develop.”
For More on EMGE Subscribe Right Now!
Currently trading at a $5.7 million market valuation EMGE has 161,351,111 shares outstanding out of 200 million authorized, 50,327,516 of which are restricted leaving just 25,523,595 free trading shares and float of 4,083,089 shares. EMGE is an exciting story developing in small caps; while the Company has little assets, they do have some revenues and are virtually debt free. In recent months the Company is in the process of completing 3 major acquisitions including Fusion Specialty Pharmacy which generated $3,801,497 in 2021 Revenues, an approximate 100% increase from 2020 Revenues of $1,971,599. They are also acquiring Revolutionary Biologistics and just announced it is closing in on the acquisition of Regen Biowellness, Inc. a distributor of various products in the plant-based and regenerative medical fields. The Acquisition is expected to close on or about August 1st, 2022. Jim Morrison, President and CEO of Regen has agreed to join Emergent’s Board of Directors upon the acquisition of Regen and additionally become the full-time CEO of Emergent upon the acquisition of Evolutionary Biologics. Mr. Morrison is a legend in the personal care industry, most notably as President of L’Oréal. While at L’Oréal, Morrison oversaw growth that averaged more than 20% year-over-year. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. New CEO Jim Morrison has big plans for Emergent including continued growth through acquisition, becoming fully reporting and uplisting to the big boards. Microcapdaily will be covering EMGE so make sure you subscribe to Microcapdaily right now so you don’t miss it.
Agree
Looking very good here
$$$ ENDP $$$
$EMGE - KidzStrips® a thin film children's toothpaste strip developed and marketed by Pending Acquisition Regen Biowellness f/k/a Availa Bio http://kidzstrips.com
Something big is cooking here, smells like rocket fuel. $EMGE
Pedal to the metal, that's for sure.
Things are shaping up beautifully.
LET'S ROCK
Me too
$EMGE Emergent Announces New Wholistic Re-Branding of all Products
HAUPPAUGE, NY / ACCESSWIRE / July 28, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces it has retained Imagemme, a leading award-winning creative branding and packaging studio to create "The Wholistic Company", a consolidation of its current and future health, wellness and regenerative products.
Emergent Health Corp., Thursday, July 28, 2022, Press release picture
The intent is to have uniform branding and develop marketing and distribution strategies for multi-channel sales approaches. This new brand will be marketed via on-line direct to consumer sales, traditional retail sales and other forms of sales channels, including TV Shopping and "Contact Purchasing."
James W. Zimbler, CEO of Emergent stated, "I couldn't be happier about the anticipated opportunity to combine and brand our current line of quality products with Regen Biowellness and Evolutionary Biologics fantastic respective product lines into one consistent brand. With the addition and expected addition to our management team of Marvin Segel, son of QVC Founder Joseph Segel with over 20 years of direct-to-consumer TV and marketing success and Jim Morrison, a legend in the personal care industry, most notably as President of L'Oréal, we believe Emergent's newly formed brand "The Wholistic Company", will become a recognizable household name to consumers."
Jim Morrison, President/CEO of Evolutionary Biologics, stated, "Imagemme is a cutting-edge branding agency. They have the ability to create a memorable brand for "The Wholistic Company" based upon the extensive portfolio of products that our combined companies will own and develop."
Marvin Segel, Chief Marketing Officer of Emergent, stated, "When I started my search for great branding, packaging, and design, I kept seeing the creative designs coming from one company … Imagemme. So, the choice was easy, and we remain impressed and excited about the new branding."
Emergent is scheduled to close the acquisitions of Regen Biowellness on Monday August 1st, 2022, Evolutionary Biologics within the next two weeks and Fusion Specialty Pharmacies during this quarter.
ABOUT EMERGENT HEALTH CORPORATION
Emergent is developing a line of products in the field of Regenerative Medicine and improved neutraceuticals and phytonutritionals available to the general public without a prescription. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. PharmaZu, its newly acquired subsidiary, is a pure play, e-commerce products and service provider focused on The Pet Community, Pet Pharmacy and Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease.
Before using any products, you should always consult with your Veterinarian and Family Doctor.
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
FOR MORE INFORMATION, PLEASE CONTACT:
James Zimbler, CEO
jzimbler@emergenthealthcompany.com
631-806-1420
https://emergenthealthcompany.com/
SOURCE: Emergent Health Corp
Awesome must watch, Thanks again sello
$EMGE
Very eye appealing, the first connection with the consumer.
Outstanding Shares is the important metric here and it is actually down 500K.
Trifecta Wam Bam
I agree Cd
No doubt about it
Looking good to go TommyBoy
$ENDP